Oncotarget: MEK is a promising target in the basal subtype of bladder cancer

(Impact Journals LLC) " The @Oncotarget authors demonstrate that MEK inhibitors are a promising targeted therapy for the basal subtype of bladder cancer, and their data indicate that drug screening of 3D cultures provides an important resource for hypothesis generation "
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news